查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513861

全球核酸检测市场

Nucleic Acid Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 372 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球核酸检测市场预计将达44亿美元

预计2023年全球核酸检测市场规模为32亿美元，预估2023年至2030年复合年增长率为4.6%，2030年达44亿美元。核酸检测套组是本报告分析的细分市场之一，预计复合年增长率为 5.1%，到分析期结束时将达到 37 亿美元。分析期间，核酸检测耗材细分市场的复合年增长率预计为 1.8%。

美国市场预估达8.718亿美元，中国预计复合年增长率为7.8%

预计2023年美国核酸检测市场规模为8.718亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到9.508亿美元，2023年至2030年复合年增长率为7.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.2% 和 5.1%。在欧洲，德国的复合年增长率预计为 2.3%。

全球核酸检测市场－主要趋势与驱动因素总结

核酸检测 (NAT) 是一种先进的生物技术，用于检测样本中 DNA 或 RNA 的特定序列。这种方法在医学诊断、法医学和生物研究等各个领域已变得至关重要。核酸检测（NAT）是一项重要的分子技术，已被用于各种诊断和筛检应用，特别是在医疗领域。它使用先进的技术来检测血液、尿液和组织中存在的病毒、细菌和其他病原体的 DNA 或 RNA 的特定序列。 NAT 市场的主要驱动力之一是其在医疗诊断中的使用不断增加。 NAT 描述了一种高度灵敏的方法，用于检测引起疾病的病毒和细菌等病原体。与培养技术等传统方法相比，直接检测病原体遗传物质的能力可以实现更快、更准确的诊断。这对于 HIV、B型肝炎、C型肝炎、结核病和 COVID-19 等感染疾病的诊断尤其重要，及时、准确的检测极大地影响治疗结果和患者康復。

技术进步透过提高这种测试方法的功能和可访问性来推动 NAT 市场的发展。聚合酵素链锁反应(PCR)、即时PCR和次世代定序(NGS) 的改进扩大了 NAT 的应用范围，使其成为更快、更准确和更具成本效益的检测方法。此外，可携式和照护现场NAT 设备的发展使即时诊断成为可能，从而将该技术的应用范围从传统实验室环境扩展到患者照护场景。这些创新支持了日益增长的个人化医疗趋势，即根据个人的基因谱量身定制治疗趋势，以提高治疗效果和患者安全。 NAT 在基因型鉴定、药物基因组学和癌症基因组学中至关重要，有助于识别可能影响某些治疗方法效果的基因突变。这种精确的方法可以提高治疗效果，最大限度地减少副作用，并改善患者的治疗效果。

NAT 在基因检测、法医学的应用不断增加，以及监管机构和政府的支持，进一步推动了市场的成长。 NAT 检测和量化微量遗传物质的能力在基因研究和诊断以及刑事调查和灾难受害者身份识别等法医学应用中变得非常宝贵。随着技术的不断发展，对准确、快速诊断的需求预计将推动 NAT 市场的显着成长，并在医疗和科学进步中发挥重要作用。

受访企业范例（46家知名企业）

  • Abbott Molecular, Inc.
  • Beckman Coulter-Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

目录

第一章调查方法

第二章执行概述

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6070

Global Nucleic Acid Testing Market to Reach US$4.4 Billion by 2030

The global market for Nucleic Acid Testing estimated at US$3.2 Billion in the year 2023, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Nucleic Acid Testing Consumables segment is estimated at 1.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$871.8 Million While China is Forecast to Grow at 7.8% CAGR

The Nucleic Acid Testing market in the U.S. is estimated at US$871.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$950.8 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Nucleic Acid Testing Market - Key Trends and Drivers Summarized

Nucleic Acid Testing (NAT) is a sophisticated biological technique used to detect specific sequences of DNA or RNA in a sample. This method has become indispensable in various fields, including medical diagnostics, forensic science, and biological research. Nucleic Acid Testing (NAT) is a vital molecular technique employed in various diagnostic and screening applications, particularly in the medical field. It utilizes advanced methodologies to detect the specific sequences of DNA or RNA from viruses, bacteria, or other pathogens present in blood, urine, or tissues. One of the primary drivers of the NAT market is its increasing use in medical diagnostics. NAT offers a highly sensitive method for detecting pathogens, including viruses and bacteria that cause diseases. Its ability to detect genetic material directly from pathogens enables earlier and more accurate diagnosis compared to traditional methods like culture techniques. This is particularly critical in the diagnosis of infectious diseases such as HIV, hepatitis B and C, tuberculosis, and COVID-19, where timely and precise detection can significantly influence treatment outcomes and patient recovery.

Technological advancements are propelling the NAT market forward by enhancing the capabilities and accessibility of this testing method. Improvements in polymerase chain reaction (PCR), real-time PCR, and next-generation sequencing (NGS) have broadened NAT's applications, making it faster, more accurate, and cost-effective. Additionally, the development of portable and point-of-care NAT devices allows for immediate diagnoses, extending the technology's reach beyond traditional lab settings into immediate patient care scenarios. These innovations support the growing trend toward personalized medicine, where treatments are tailored based on individual genetic profiles, improving treatment efficacy and patient safety. NAT is crucial in genotyping, pharmacogenomics, and cancer genomics, helping to identify genetic mutations that may influence the effectiveness of certain therapies. This precise approach enhances treatment efficacy and minimizes adverse drug reactions, leading to better patient outcomes.

The increasing application of NAT in genetic testing, forensic science, and the support of regulatory bodies and governments further boost market growth. NAT's ability to detect and quantify minute amounts of genetic material makes it invaluable in genetic research and diagnostics, as well as in forensic applications for identifying individuals in criminal investigations and disaster victim identification. As technology continues to evolve, the demand for precise and rapid diagnostics is expected to drive substantial growth in the NAT market, affirming its integral role in healthcare and scientific advancements.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Beckman Coulter - Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Nucleic Acid Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Infectious Diseases Drives Nucleic Acid Testing Market Growth
    • Technological Advancements in PCR and NGS Propel Market Expansion
    • Increasing Adoption in Clinical Diagnostics Expands Addressable Market
    • Rising Demand for Point-of-Care Testing Generates Market Opportunities
    • Expansion of Molecular Diagnostic Laboratories Accelerates Market Growth
    • Growing Focus on Early Disease Detection Sustains Market Growth
    • Increasing Use in Oncology and Cancer Research Spurs Market Adoption
    • Advances in CRISPR and Gene Editing Technologies Generate Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nucleic Acid Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Nucleic Acid Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION